Pain Medicine, Interventional Pain Medicine · Brooksville, FL
NPI
1295789444
Since 2006
Specialty
Pain Medicine, Interventional Pain Medicine
Code 208VP0014X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
12148 Cortez Blvd
Brooksville, FL, 34613
Phone (352) 597-7184
Groups this clinician bills Medicare through
Medicare paid, 2024
$224K
4,442 services
Medicare patients, 2024
230
Average age 69
Drug cost, 2024
$403K
11,489 prescriptions
Company payments, 2025
$21.49
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eyad Alsabbagh was code J1100 (injection, dexamethasone sodium phosphate, 1 mg), 2,120 times for 76 patients. In total Eyad Alsabbagh billed 4,442 services in 22 codes, and Medicare paid $224K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,120 | 76 | $0.09 | $194 |
| 99214 Office E&M - Established | Office | 1,265 | 198 | $88.84 | $112K |
| 97750 Occupational Therapy | Office | 276 | 39 | $19.74 | $5,448 |
| 80307 Drug Tests | Office | 102 | 95 | $60.90 | $6,212 |
| 64493 Nerve Block Injection - Back | Office | 92 | 47 | $129.20 | $12K |
| 64494 Nerve Block Injection - Back | Office | 92 | 47 | $67.77 | $6,235 |
| 64636 Destruction by Neurolytic Agent - Back | Office | 80 | 40 | $167.24 | $13K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 72 | 40 | $333.27 | $24K |
| 99204 Office E&M - New | Office | 58 | 58 | $107.09 | $6,211 |
| 64484 Nerve Block Injection - Back | Office | 44 | 24 | $84.72 | $3,728 |
| 64483 Nerve Block Injection - Back | Office | 44 | 24 | $183.93 | $8,093 |
| 99213 Office E&M - Established | Office | 40 | 35 | $70.38 | $2,815 |
| 64491 Nerve Block Injection - Back | Office | 38 | 21 | $73.54 | $2,795 |
| 64490 Nerve Block Injection - Back | Office | 37 | 21 | $137.71 | $5,095 |
| 64634 Destruction by Neurolytic Agent - Back | Office | 23 | 12 | $190.92 | $4,391 |
By year: 2022 $363K for 8,648 services; 2023 $330K for 8,488 services; 2024 $224K for 4,442 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 102 | 95 | $60.90 | $6,212 |
Medicare prescription drug claims, 2024
In 2024, the drug Eyad Alsabbagh prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 2,792 prescriptions and refills. In total Eyad Alsabbagh wrote 11,489 Medicare prescriptions that cost $403K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 2,792 | 2,792 | 386 | $75K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,096 | 2,096 | 262 | $72K |
| Morphine Sulfate Er Morphine Sulfate | 1,713 | 1,713 | 205 | $37K |
| Tizanidine Hcl Generic | 1,313 | 2,065 | 360 | $23K |
| Morphine Sulfate Generic | 920 | 920 | 119 | $15K |
| Oxycodone Hcl Generic | 490 | 490 | 52 | $10K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 384 | 396 | 62 | $97K |
| Tramadol Hcl Generic | 349 | 349 | 102 | $4,225 |
| Meloxicam Generic | 294 | 466 | 64 | $969 |
| Methadone Hcl Generic | 267 | 267 | 34 | $4,341 |
| Fentanyl Generic | 217 | 217 | 25 | $16K |
| Gabapentin Generic | 140 | 244 | 34 | $3,067 |
| Baclofen Generic | 123 | 195 | 27 | $2,618 |
| Pregabalin Generic | 89 | 107 | 17 | $7,898 |
| Cyclobenzaprine Hcl Generic | 77 | 143 | 25 | $907 |
Brand drugs: 598 claims; generic drugs: 10,891 claims; opioid claims: 8,908.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eyad Alsabbagh $21.49 ($21.49 in general payments such as food, travel and fees) from 1 company. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $21.49.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $21.49 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.